Indications
Therapeutic Asset Ratings
13,145 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fexagratinib
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P2
B
(57)
Fexagratinib
Refractory Malignant Neoplasm
National Cancer Institute (NCI)
P2
B
(57)
Flortaucipir
Depressive Disorder
Washington University School of Medicine
P2
B
(57)
Floxuridine
Cholangiocarcinoma
National Cancer Institute (NCI)
P2
B
(57)
Fludarabine
Chronic Leukemia
Roswell Park Cancer Institute
P2
B
(57)
Fludarabine
Inborn Error Of Immunity
Paul Szabolcs
P2
B
(57)
Fludarabine
GATA2 Deficiency With Susceptibility To MDS/AML
Fred Hutchinson Cancer Center
P2
B
(57)
Fludarabine
SAMD9L-Related Spectrum And Myeloid Neoplasm Risk
Fred Hutchinson Cancer Center
P2
B
(57)
Fludarabine
SAMD9-Related Spectrum And Myeloid Neoplasm Risk
Fred Hutchinson Cancer Center
P2
B
(57)
Fludarabine
Inherited Sideroblastic Anemia
Fred Hutchinson Cancer Center
P2
B
(57)
Fludarabine
Langerhans Cell Histiocytosis
M.D. Anderson Cancer Center
P2
B
(57)
Fludeoxyglucose
Her2-Receptor Negative Breast Cancer
University of Washington
P2
B
(57)
Fludeoxyglucose
Mesothelioma
National Cancer Institute (NCI)
P2
B
(57)
Fludeoxyglucose
Parkinson Disease
Universitaire Ziekenhuizen KU Leuven
P2
B
(57)
Flumatinib
Chronic Myeloid Leukemia
The First Affiliated Hospital of Soochow University
P2
B
(57)
Fluorouracilum
Anal Canal Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
B
(57)
Fluorouracilum
Endometrial Cancer
Merck Sharp & Dohme LLC
P2
B
(57)
Fluorouracilum
Anal Canal Carcinoma
ECOG-ACRIN Cancer Research Group
P2
B
(57)
Fluorouracilum
Secondary Malignant Neoplasm
Ludwig-Maximilians - University of Munich
P2
B
(57)
Fluorouracilum
Urinary Bladder Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Fluorouracilum
Uterine Cervix Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Flutamide
Prostate Carcinoma
M.D. Anderson Cancer Center
P2
B
(57)
Fluzoparib
Small Cell Lung Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P2
B
(57)
ga-68 dolacga
Hepatocellular Carcinoma
National Atomic Research Institute, Taiwan
P2
B
(57)
Gabapentin
Bipolar Disorder
Medical University of South Carolina
P2
B
(57)
Showing 3101 to 3125 of 13,145 assets
Previous
Page 125 of 526
Next